CORRECTION article

Front. Pharmacol., 06 January 2025

Sec. Renal Pharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1548193

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

  • GL

    Guangzhuang Li 1

  • SX

    Sentao Xian 2

  • XC

    Xianchao Cheng 3

  • YH

    Yunhua Hou 1

  • WJ

    Wenqing Jia 2*

  • YM

    Yukui Ma 2*

  • 1. School of Bioengineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, China

  • 2. School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan, China

  • 3. Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China

In the published article, there was an error in Affiliation 1. Instead of “School of Bioengineering, Shandong Academy of Sciences, Qilu University of Technology, Jinan, China,” it should be “School of Bioengineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Oroxylin A, chronic kidney disease, renal fibrosis, Sirt1, molecular docking

Citation

Li G, Xian S, Cheng X, Hou Y, Jia W and Ma Y (2025) Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation. Front. Pharmacol. 15:1548193. doi: 10.3389/fphar.2024.1548193

Received

19 December 2024

Accepted

20 December 2024

Published

06 January 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Wenqing Jia, ; Yukui Ma,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics